|
1
|
Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis.
|
Nat Genet
|
2003
|
5.82
|
|
2
|
Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis.
|
Nat Genet
|
2002
|
4.19
|
|
3
|
Treatment of Waldenström's macroglobulinemia with rituximab.
|
J Clin Oncol
|
2002
|
1.35
|
|
4
|
Genetic hyperferritinaemia and reticuloendothelial iron overload associated with a three base pair deletion in the coding region of the ferroportin gene (SLC11A3).
|
Br J Haematol
|
2002
|
1.32
|
|
5
|
Extended rituximab therapy for previously untreated patients with Waldenström's macroglobulinemia.
|
Clin Lymphoma
|
2002
|
0.89
|
|
6
|
Effective hemostasis with rFVIIa treatment in two patients with severe thrombocytopenia and life-threatening hemorrhage.
|
Am J Hematol
|
2002
|
0.87
|
|
7
|
Analysis of SLC40A1 gene at the mRNA level reveals rapidly the causative mutations in patients with hereditary hemochromatosis type IV.
|
Blood Cells Mol Dis
|
2007
|
0.83
|
|
8
|
beta(S)-Globin gene cluster haplotypes in the West Bank of Palestine.
|
Hemoglobin
|
2009
|
0.78
|
|
9
|
On the mechanism of action of recombinant activated factor VII administered to patients with severe thrombocytopenia and life-threatening haemorrhage: focus on prothrombin activation.
|
Br J Haematol
|
2002
|
0.77
|
|
10
|
Hypochromic erythrocytes (%): a reliable marker for recognizing iron-restricted erythropoiesis and predicting response to erythropoietin in anemic patients with myeloma and lymphoma.
|
Ann Hematol
|
2007
|
0.76
|
|
11
|
Evaluation of hypochromic erythrocytes in combination with sTfR-F index for predicting response to r-HuEPO in anemic patients with multiple myeloma.
|
Lab Hematol
|
2006
|
0.75
|